Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

ENDRA Life Sciences (NDRA) Stock Price & Analysis

861 Followers

NDRA Stock Chart & Stats

$4.86$0.06(1.25%)
At close: 4:00 PM EST
$4$5$6Aug 10Aug 24Sep 8Sep 21Oct 5Oct 19Nov 2
Day’s Range
$4.75 - $4.95
52-Week Range
$2.96 - $6.95
Previous Close
$4.80
Volume
N/A
Average Volume (3M)
17.90K
Market Cap
$7.20M
Enterprise Value
$1.95M
Total Cash (Recent Filing)
$1.74M
Total Debt (Recent Filing)
$429.27K
Price to Earnings (P/E)
―
Beta
1.81
Next Earnings
Nov 16, 2026 (Est.)
EPS Estimate
-0.84
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Low Leverage

Modest debt limits near-term solvency pressure and leaves the company less exposed to interest obligations than a highly leveraged peer. This provides some financial flexibility while ENDRA works toward commercialization, although it does not offset the need to fund ongoing losses.

Narrowing Losses

The reduction in net losses indicates improving cost absorption or operating discipline over time, which could extend financial runway if sustained. However, the benefit remains preliminary because revenue is still absent, so further progress depends on converting the platform into commercial sales.

Greater Transaction Flexibility

Revised merger and financing terms may improve the parties' ability to complete the planned combination and secure capital for execution. The changes provide greater flexibility around closing liquidity and funding capacity, potentially supporting strategic development if shareholder and closing conditions are satisfied.

Bears Say

No Revenue Traction

Persistent zero revenue shows that ENDRA has not yet demonstrated commercial adoption of its imaging platform or established a recurring customer base. Until meaningful sales begin, the business remains dependent on development progress and external funding rather than internally generated operating income.

Heavy Cash Burn

Sustained negative operating and free cash flow means ENDRA is consuming capital to maintain operations and advance its business. Continued burn can shorten financial runway and increase reliance on capital raises or other funding, especially if revenue commercialization takes longer than expected.

Nasdaq Compliance Risk

The monitoring period creates an ongoing corporate and financing risk because another compliance deficiency could threaten continued Nasdaq listing. That possibility may complicate access to investors, increase administrative pressure, and distract management while the company is still working toward commercialization.

ENDRA Life Sciences News

NDRA FAQ

What was ENDRA Life Sciences’s price range in the past 12 months?
ENDRA Life Sciences lowest stock price was $2.96 and its highest was $6.95 in the past 12 months.
What is ENDRA Life Sciences’s market cap?
ENDRA Life Sciences’s market cap is $7.20M.
When is ENDRA Life Sciences’s upcoming earnings report date?
ENDRA Life Sciences’s next earnings report is estimated for Nov 16, 2026 (not yet confirmed), which is in 12 days.
How were ENDRA Life Sciences’s earnings last quarter?
ENDRA Life Sciences released its earnings results on Aug 17, 2026. The company reported $0.121 earnings per share for the quarter, beating the consensus estimate of -$0.84 by $0.961.
Is ENDRA Life Sciences overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does ENDRA Life Sciences pay dividends?
ENDRA Life Sciences does not currently pay dividends.
What is ENDRA Life Sciences’s EPS estimate?
ENDRA Life Sciences’s EPS estimate is -0.84.
How many shares outstanding does ENDRA Life Sciences have?
ENDRA Life Sciences has 1,499,838 shares outstanding.
What happened to ENDRA Life Sciences’s price movement after its last earnings report?
ENDRA Life Sciences reported an EPS of $0.121 in its last earnings report, beating expectations of -$0.84. Following the earnings report the stock price went up 0.447%.
Which hedge fund is a major shareholder of ENDRA Life Sciences?
Currently, no hedge funds are holding shares in NDRA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology